Hospital prices for services have little consistency

As the Trump administration continues to put forth efforts to reduce drug costs, hospital prices will likely become more transparent. For now, prices remain somewhat obscure—and vary widely for the same procedures, according to an analysis by Axios.

For example, the price for joint replacement surgery, one of the most common inpatient procedures, was at least $30,000 in nine out of 10 hospitals analyzed by Axios. And one of six hospitals charged $90,000 or more, Axios concluded, citing 2016 federal healthcare data.

Hospitals can set procedure prices however they want—and Medicare will pay it. However, Medicare pays less than $13,000 on average for a joint replacement even though prices are “all over the map.”

For-profit hospitals tended to have higher prices, but some not-for-profit hospital systems also had some of the highest prices for joint replacements, according to Axios. And hospitals continually raise their prices to charge even higher rates.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Cardiovascular devices are more likely to be in a Class I recall than any other device type. The FDA's approval process appears to be at least partially responsible, though the agency is working to make some serious changes. We spoke to a researcher who has been tracking these data for years to learn more. 

Updated compensation data includes good news for multiple subspecialties. The new report also examines private equity's impact on employment models and how much male cardiologists earn compared to females.

When drugs are on the FDA’s shortage list, outsourcing facilities can produce their own compounded versions. When the FDA removed tirzepatide from that list with no warning, it created a considerable amount of chaos both behind the scenes and in pharmacies all over the country. 

Trimed Popup
Trimed Popup